Dual-Pathway Mitochondrial Structure & Signalling Stack
8-12 weeks
Daily subcutaneous injection
2 peptides
The Mitochondrial Restoration Protocol combines SS-31 (Elamipretide) — the first FDA-approved drug targeting mitochondrial dysfunction — with MOTS-C, a mitochondria-derived peptide studied for metabolic signalling and AMPK activation. SS-31 selectively binds cardiolipin on the inner mitochondrial membrane to restore cristae architecture and optimize electron transport chain function, while MOTS-C activates AMPK-mediated metabolic pathways for comprehensive metabolic homeostasis. Together, these compounds address both the structural and signalling dimensions of mitochondrial decline — the most targeted dual-pathway mitochondrial protocol available. Both compounds are supplied as lyophilized vials from Peptides Pharma. This protocol is for research purposes only.
SS-31 (D-Arg-Dmt-Lys-Phe-NH2) concentrates >1000-fold within mitochondria due to its Szeto-Schiller targeting sequence. Once at the inner membrane, it binds cardiolipin — the phospholipid essential for cristae structure and electron transport chain complex anchoring. This binding prevents cardiolipin peroxidation and converts cytochrome c from peroxidase activity back to electron-carrying function, simultaneously reducing ROS and enhancing ATP production. MOTS-C complements this structural repair by activating AMPK — the master metabolic regulator — promoting glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. The combination addresses mitochondrial dysfunction at both the physical membrane level (SS-31) and metabolic signalling level (MOTS-C).
SS-31 and MOTS-C target complementary layers of mitochondrial function. SS-31 directly stabilizes the inner membrane structure (cardiolipin binding, cristae architecture, ETC optimization), while MOTS-C activates metabolic signalling (AMPK, glucose metabolism, fatty acid oxidation). Think of SS-31 as repairing mitochondrial hardware and MOTS-C as optimizing mitochondrial software.
SS-31 (Elamipretide/Forzinity) is the first and only FDA-approved drug specifically targeting mitochondrial dysfunction, approved for Barth syndrome. This FDA approval validates the mechanism of cardiolipin-targeted therapy and establishes SS-31's safety and efficacy profile through rigorous clinical trial data (TAZPOWER trial).
SS-31 has demonstrated measurable effects on mitochondrial respiration within one hour in aged skeletal muscle. MOTS-C metabolic effects (AMPK activation, glucose metabolism improvements) typically become measurable within 1-2 weeks. The full protocol duration of 8-12 weeks allows comprehensive assessment of sustained mitochondrial remodelling.
Yes, adding NAD+ creates the comprehensive Mitochondrial Research Stack (SS-31 + MOTS-C + NAD+). NAD+ provides the bioenergetic substrate for sirtuin activation and mitochondrial biogenesis, adding a third dimension to the structural (SS-31) and signalling (MOTS-C) approach. See the Mitochondrial Research Stack bundle for savings.
Both SS-31 and MOTS-C are supplied as lyophilized powder in sealed vials. Reconstitute each separately with bacteriostatic water according to the included instructions. Administer as separate daily subcutaneous injections. Store reconstituted vials refrigerated and use within 30 days.
SS-31 is the first FDA-approved drug targeting mitochondrial dysfunction. Learn about its cardiolipin mechanism, clinical trials, anti-aging research, and where to buy research-grade vials.
ARTICLESS-31 targets cardiolipin on the inner membrane while MOTS-C activates AMPK signalling. Compare mechanisms, evidence, and when to use each mitochondrial peptide.
ARTICLEBuy Humanin >99% purity, GMP certified. MT-RNR2-encoded cytoprotective peptide for longevity research. Vials from €99 with worldwide delivery.
COMPARISONCompare SS-31 (Elamipretide) and MOTS-C for mitochondrial research. Mechanisms, clinical evidence, anti-aging potential, and how to combine them. Buy research-grade peptide vials.
ENCYCLOPEDIAMitochondria-Targeted Peptide (Szeto-Schiller Peptide). Molecular weight: 639.78 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEThe ultimate triple-compound mitochondrial restoration protocol
PROTOCOLResearch protocol combining Epithalon, MOTS-C, SS-31, and NAD+ lyophilized vials for comprehensive longevity investigation. Explore telomerase activation, mitochondrial restoration, and cellular energy research.
FAQSS-31 (Elamipretide) research FAQ. Learn about mitochondrial targeting, cardiolipin interaction, purity, storage, reconstitution, and research applications.
CATEGORYResearch-grade longevity peptides targeting the hallmarks of aging. Epithalon telomerase activation, MOTS-C mitochondrial function, Humanin cytoprotection, NAD+ sirtuin pathways, SS-31, GHK-Cu, Thymosin Alpha-1. >99% purity.
All Peptides Pharma research vials are pre-mixed, >99% purity, GMP manufactured with worldwide delivery.
FOR RESEARCH PURPOSES ONLY. NOT INTENDED FOR SELF-ADMINISTRATION.
SHOP RESEARCH VIALS
